CLINICAL_TRIALS
trial_result
· 2022-03-31
Clinical Trial Update: InO - A Retrospective Study of UK Patients With Leukaemia
Summary
A retrospective UK study of InO (inotuzumab ozogamicin) in patients with precursor cell lymphoblastic leukemia-lymphoma has been completed with results posted i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma | Status: COMPLETED | Results posted: 2022-03-31